ABVC BioPharma, Inc. (NASDAQ: ABVC) ("ABVC" or the "Company"), a clinical-stage biopharmaceutical company focused on botanical-derived therapeutics and commercial ingredient platforms, today ...
BIO-key International (BKYI) announced on Wednesday that Nasdaq has flagged the company for non-compliance due to a delay in filing its Q1 2026 Form 10-Q for the period ended March 31, 2026. Nasdaq’s ...
BIO-key International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification ...
Earnings Call Insights: BIO-key International, Inc. (BKYI) Q3 2025 DePasquale stated, "we expect continuing deployments in orders even this quarter and beyond" with the large banking customer, ...
CommentaryBIO-key CEO, Mike DePasquale commented, “We had a very productive third quarter, with revenue increasing 18% year-over-year and $1M compared to Q2’24, supported by license fee revenue which ...
BIO-key International ( (BKYI) ) just unveiled an announcement.
6d
BIO-key’s RedChip Future Tech Investor Conference Presentation to be Webcast Wed. June 10 at 3pm ET
BIO-key® International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that Michael DePasquale, Chairman and CEO ...
BIO-key ® International, Inc. (OTC Markets: BKYI), a provider of biometric authentication technologies used by leading military and defense ministries, announced that its CEO Michael DePasquale will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results